| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |